![Andrew Aromando](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Aromando
Corporate Officer/Principal at
ONCOLYTICS BIOTECH INC.
Net worth: 57 304 $ as of 2026-05-30
Profile
Andrew P.
Aromando is Chief Business Officer at Oncolytics Biotech, Inc. since 2025.
Mr. Aromando is Chief Operating Officer at Ambrx Biopharma Cayman, Inc. since 2023.
Formerly, Mr. Aromando was SVP-Commercial Development & Operations at Tamir Biotechnology, Inc. Mr. Aromando was Vice President-North American Business Development at Innovex LP from 2000 to 2004.
Mr. Aromando was Chief Operating Officer at Ambrx Biopharma Cayman, Inc. Mr. Aromando was Chief Operating Officer at Ambrx, Inc. from 2023 to 2024.
Mr. Aromando completed undergraduate studies at The College of New Jersey and graduate studies at Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 55,100 ( 0.05% ) | 57 304 $ | 2026-05-30 |
Andrew Aromando active positions
| Companies | Position | Start |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Corporate Officer/Principal | 2025-06-29 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Chief Operating Officer | 2023-04-27 |
Former positions of Andrew Aromando
| Companies | Position | End |
|---|---|---|
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Chief Operating Officer | 2024-03-07 |
| AMBRX INC | Chief Operating Officer | 2024-02-29 |
Innovex LP
 Innovex LP Miscellaneous Commercial ServicesCommercial Services Provides contract product development services | Corporate Officer/Principal | 2003-12-31 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Chief Operating Officer | - |
Training of Andrew Aromando
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Provides contract product development services | Commercial Services |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
- Stock Market
- Insiders
- Andrew Aromando
